Ascentage Pharma Group Internat
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2023 | — | — | $142.2M |
| FY2024 | $121.9M | $36.2M | $122.4M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2023 | — | — | $142.2M |
| FY2024 | $121.9M | $36.2M | $122.4M |